Collaboration and License Agreements (Tables)

6 Months Ended

Jun. 30, 2021

Collaboration And License Agreements [Abstract]

Schedule of Revenue from Collaboration Agreements

Revenue from collaboration agreements for the three and six months ended June 30, 2021 and 2020 in the condensed consolidated statements of operations and comprehensive loss was as follows (in thousands):

	Three Months Ended June 30,				Six Months Ended June 30,
	2021		2020		2021		2020
Revenue from collaboration agreements:
Roche Agreement	$	2,893	$	3,760	$	5,086	$	6,029
Biogen Agreement		2,940		2,306		4,820		3,302
Calico Agreement		3,948		3,604		7,301		7,155
Total revenue from collaboration agreements	$	9,781	$	9,670	$	17,207	$	16,486

Schedule of Financial Information Related to Collaboration and License Agreements

Financial information related to the collaboration and license agreements consisted of the following in the Company’s condensed consolidated balance sheet as of June 30, 2021 (in thousands):

	Accounts Receivable		Deferred Revenue, Current		Deferred Revenue, Net of Current		Deferred Revenue, Total
Supplemental information:
Roche Agreement	$	750	$	7,734	$	26,909	$	34,643
Biogen Agreement		3,115		19,161		19,280		38,441
Calico Agreement		2,348		1,800		—		1,800
Total	$	6,213	$	28,695	$	46,189	$	74,884

13

Financial information related to the collaboration and license agreements consisted of the following in the Company’s condensed consolidated balance sheet as of December 31, 2020 (in thousands):

	Accounts Receivable		Deferred Revenue, Current		Deferred Revenue, Net of Current		Deferred Revenue, Total
Supplemental information:
Roche Agreement	$	750	$	11,238	$	26,991	$	38,229
Biogen Agreement		776		13,965		26,026		39,991
Calico Agreement		2,958		2,400		600		3,000
Total	$	4,484	$	27,603	$	53,617	$	81,220

Schedule of Supplemental Financial Information Related to Collaboration and License Agreements

Supplemental financial information related to the collaboration and license agreements for the three and six months ended June 30, 2021 and 2020 are (in thousands):

	Three Months Ended June 30,				Six Months Ended June 30,
	2021		2020		2021		2020
Revenue recognized that was included in the contract liability at the beginning of the period	$	5,535	$	5,312	$	10,054	$	8,808
Revenue recognized from performance obligations fully or partially satisfied in previous periods		713		227		713		227